0000899243-22-007015.txt : 20220218 0000899243-22-007015.hdr.sgml : 20220218 20220218160557 ACCESSION NUMBER: 0000899243-22-007015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220216 FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brudnick Richard CENTRAL INDEX KEY: 0001692359 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39615 FILM NUMBER: 22652686 MAIL ADDRESS: STREET 1: BIOVERATIV INC. STREET 2: 225 SECOND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Codiak BioSciences, Inc. CENTRAL INDEX KEY: 0001659352 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGEPARK DRIVE STREET 2: SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-949-4100 MAIL ADDRESS: STREET 1: 35 CAMBRIDGEPARK DRIVE STREET 2: SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: Codiak Biosciences, Inc. DATE OF NAME CHANGE: 20151125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-16 0 0001659352 Codiak BioSciences, Inc. CDAK 0001692359 Brudnick Richard C/O CODIAK BIOSCIENCES, INC. 35 CAMBRIDGEPARK DRIVE, SUITE 500 CAMBRIDGE MA 02140 0 1 0 0 See Remarks Stock Option (Right to Buy) 5.21 2022-02-16 4 A 0 10850 0.00 A 2032-02-15 Common Stock 10850 10850 D Restricted Stock Units 2022-02-16 4 A 0 16275 0.00 A Common Stock 16275 16275 D 25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of common stock. On February 16, 2022, the reporting person was granted 16,275 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date. Officer title: Chief Business Officer and Head of Corporate Strategy /s/ Yalonda Howze, Attorney-in-Fact for Richard Brudnick 2022-02-18